













|
|
Steve C. Huang,
Zhengping Zhuang, Robert J. Weil, Svetlana Pack, Chaoyu Wang, Henry C. Krutzsch,
Thu A. Pham, and Irina A. Lubensky |
| |
From
the Laboratory of Pathology (SCH, ZZ, SP, CW, HCK, TAP, IAL), National Cancer
Institute, and Surgical Neurology Branch (RJW), National Institute of Neurological
Diseases and Stroke, National Institutes of Health, Bethesda, Maryland |
| |
Although the gene responsible for multiple endocrine neoplasia, type
1 (MEN1) has been identified recently, the function of its gene product,
menin, is not known. To examine menin's biological role, we created an
N-terminal tagged fusion protein to follow the distribution of menin in
the cell. In all cell lines tested, menin was found both in the nucleus
and the cytoplasm, but its localization was dependent on the phase of
the cell cycle; during a nondividing phase, menin was found in the nucleus;
during and immediately after cell division, it was found in the cytoplasm.
To confirm the cellular localization seen with the N-terminal tagged protein,
we developed and purified peptide-specific antibodies. One of these antibodies
(NCI 624), which recognizes a domain (aa 383-395) of menin, was used in
immunofluorescence studies to corroborate the N-terminal tagging results.
Further confirmation of menin localization was obtained in a pituitary
tumor cell line derived from a familial MEN1 patient, which contained
a mixed cell population with either none, or one functional copy of the
MEN1 gene. Our results indicate that menin functions principally
as a nuclear protein but may be found in the cytoplasm during cell division.
(Lab Invest 1999, 79:301-310).
|